Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

— —

John J. Tobin (ChemHaz Solutions, Clare County, Ireland) Gary Walsh (ChemHaz Solutions, Clare County, Ireland)

Medical Product Regulatory Affairs

Pharmaceuticals, Diagnostics, Medical Devices

John J. Tobin (ChemHaz Solutions, Clare County, Ireland), Gary Walsh (ChemHaz Solutions, Clare County, Ireland)

$183.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Blackwell Verlag GmbH
11 October 2023

Clinical & internal medicine; Chemistry; Biology, life sciences

Medical Product Regulatory Affairs Hands-on guide through the jungle of medical regulatory affairs for every professional involved in bringing new products to market

Based on a module prepared by the authors for an MSc course offered by the University of Limerick, Ireland, Medical Product Regulatory Affairs is a comprehensive and practical guide on how pharmaceutical and medical devices are regulated within the major global markets. The Second Edition builds on the success of the first with an even wider scope and full coverage of new EU regulations on the safe use of medical devices.

Following a look at drug development, complete sections are devoted to national and EU regulatory issues, manufacturing license application and retention, and regulation in the USA. Other topics dealt with include CDER, CBER and

marketing and manufacturing licenses, the ICH process and Good Laboratory/Clinical/ Manufacturing Practices.

Medical Product Regulatory Affairs includes information on:

Aims and structure of regulation, covering purpose and principles of regulation, national and EU legislative processes, and pharmacopeia Regulatory strategy, covering product development and manufacturing, market vigilance, quality assurance systems, personnel, and documentation Drug discovery and development, covering prescription status, physical

properties, therapeutic use, and drug discovery, development, and delivery Non-clinical studies, covering non-clinical study objectives and timing, pharmacological and pharmacodynamic studies, and bioavailability and bioequivalence Clinical trials, covering trial protocol, monitoring of trials, trial master files, and FDA communications

The wide coverage of different product types and the main global markets makes Medical Product Regulatory Affairs ideal for training courses on regulatory affairs in academia and industry. It is also a valuable reference for pharmacologists, bioengineers, pharma engineers, and students in pharmacy to familiarize themselves with the topic.

By: John J. Tobin (ChemHaz Solutions Clare County Ireland), Gary Walsh (ChemHaz Solutions, Clare County, Ireland)
Imprint: Blackwell Verlag GmbH
Country of Publication: Germany
Edition: 2nd edition
Dimensions: Height: 240mm, Width: 20mm, Spine: 170mm
Weight: 680g
ISBN: 9783527333264
ISBN 10: 3527333266
Pages: 336
Publication Date: 11 October 2023
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

John J. Tobin worked for many years and in various capacities within Olympus diagnostica GmbH, a company that employed several 100 people to develop and manufacture in vitro diagnostic reagents. Gary Walsh is chair of industrial biotechnology at the University of Limerick, Ireland. He has direct industrial experience within the pharmaceutical and diagnostic industries as well as extensive teaching and research interests in the pharmaceutical and biotechnology arena.